Excellent course on strategies for drug commercialization including pharmacoeconomics and how pharma partners with other stakeholders to accomplish this. Excellent examples of drug lifecycles.
Excellent content and lecturers. Great course to finish this specialization. I strongly recommend the three courses for those interested in pursuing a career in pharma or willing to shift.
创建者 Kierstin L•
Etouillie was great and his experience commentary made the course more interesting. His biosimilar section is highly pertinent to the US current situation with lawsuits flying every which way. I do wish more regulatory process steps were included. The start up success last section was not helpful. More just seemed like a quick review article one could read about an approved drug and the story of someone bragging about how lucky they were.
创建者 Danna F M•
The course was very interesting and cover differents topics to give me an overview of drug commercialization in USA. In addition, the experiences shared from the each professor was excelent. However, I didn't know that the majority of topics were made in 2013. So this information was missing when I applied for this course.
创建者 George L•
I found this course to be very engaging and informative about the Drug Development Process. However, most of the information is outdated - the course was recorded in 2015 and a lot has changed in pharma since then. I would give it a 5-stare rating if I had taken the course say 4-5 years ago.
创建者 Alexander B•
Most of materials are quite outdated and also quality of presentations sometimes was not that good.
创建者 Richik N M•
Not enough materials on HEOR and Phase IV studies. Week 4's lectures were redundant.
创建者 Saudamini R•
Its a wonderful course, but i would request the faculty to include more recent data
创建者 Muhammed T k•
some lectures are not understand
创建者 Vincent L•
It was alright, couldve given more examples and cases
创建者 yousef e•
i think part one in week 4 is too bad
创建者 Aline M B M•